From a therapeutic standpoint, tumors with persistent STAT3 activation, a hallmark of therapy-resistant NSCLC, may represent a subset particularly amenable to ferroptosis-based radiosensitization. Here, STAT3 is linked to non-small cell lung carcinoma.